title: Re-evaluation of the efficacy of the association of cabergoline to somatostatin analogues in acromegalic patients.
authors.forename: Blandine
authors.initials: B
authors.lastname: Gatta
authors.forename: Doan Huu
authors.initials: DH
authors.lastname: Hau
authors.forename: Bogdan
authors.initials: B
authors.lastname: Catargi
authors.forename: Patrick
authors.initials: P
authors.lastname: Roger
authors.forename: Antoine
authors.initials: A
authors.lastname: Tabarin
mesh_terms: D000172:Acromegaly / Q000097:blood / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D018491:Dopamine Agonists; D004873:Ergolines; D007334:Insulin-Like Growth Factor I; D000077465:Cabergoline; D015282:Octreotide